Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.

Pettersson N, Johansson KA, Alsadius D, Tucker SL, Steineck G, Olsson C.

Acta Oncol. 2014 Jun;53(6):815-21. doi: 10.3109/0284186X.2013.870669. Epub 2014 Jan 24.

PMID:
24460070
2.
3.
4.

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.

Georg D, Hopfgartner J, Gòra J, Kuess P, Kragl G, Berger D, Hegazy N, Goldner G, Georg P.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):715-22. doi: 10.1016/j.ijrobp.2013.11.241.

PMID:
24521685
5.

Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Nitsche M, Brannath W, Brückner M, Wagner D, Kaltenborn A, Temme N, Hermann RM.

Br J Radiol. 2017 Feb;90(1070):20160370. doi: 10.1259/bjr.20160370. Epub 2016 Dec 12.

PMID:
27936891
6.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, Gustafson G, Ye H, Martinez A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):204-12. doi: 10.1016/j.ijrobp.2010.10.009. Epub 2010 Dec 16.

PMID:
21167653
8.

The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.

Rylander S, Buus S, Bentzen L, Pedersen EM, Tanderup K.

Brachytherapy. 2015 Sep-Oct;14(5):711-7. doi: 10.1016/j.brachy.2015.06.001. Epub 2015 Jul 9.

PMID:
26164752
9.

Three-dimensional dose addition of external beam radiotherapy and brachytherapy for oropharyngeal patients using nonrigid registration.

Vásquez Osorio EM, Hoogeman MS, Teguh DN, Al-Mamgani A, Kolkman-Deurloo IK, Bondar L, Levendag PC, Heijmen BJ.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1268-77. doi: 10.1016/j.ijrobp.2010.10.006. Epub 2010 Dec 2.

10.

Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.

Van de Kamer JB, De Leeuw AA, Moerland MA, Jürgenliemk-Schulz IM.

Radiother Oncol. 2010 Feb;94(2):248-53. doi: 10.1016/j.radonc.2009.12.011. Epub 2010 Jan 18.

PMID:
20080309
11.

Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.

Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH.

Jpn J Clin Oncol. 2008 Jul;38(7):474-9. doi: 10.1093/jjco/hyn056. Epub 2008 Jul 11.

PMID:
18621848
12.

Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based addition.

Moulton CR, House MJ, Lye V, Tang CI, Krawiec M, Joseph DJ, Denham JW, Ebert MA.

J Med Imaging Radiat Oncol. 2017 Feb 9. doi: 10.1111/1754-9485.12593. [Epub ahead of print]

PMID:
28185419
13.

Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.

Nesvacil N, Pötter R, Sturdza A, Hegazy N, Federico M, Kirisits C.

Radiother Oncol. 2013 Apr;107(1):75-81. doi: 10.1016/j.radonc.2012.09.005. Epub 2012 Oct 12.

15.

Predicting dose-volume histograms for organs-at-risk in IMRT planning.

Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL.

Med Phys. 2012 Dec;39(12):7446-61. doi: 10.1118/1.4761864.

PMID:
23231294
16.

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.

Okamoto M, Ishikawa H, Ebara T, Kato H, Tamaki T, Akimoto T, Ito K, Miyakubo M, Yamamoto T, Suzuki K, Takahashi T, Nakano T.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e211-7. doi: 10.1016/j.ijrobp.2011.03.041. Epub 2011 May 27.

PMID:
21620579
18.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5. Epub 2009 Nov 10.

PMID:
19899007
19.

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.

Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K.

J Radiat Res. 2014 Nov;55(6):1114-21. doi: 10.1093/jrr/rru048. Epub 2014 Jun 23.

20.

Supplemental Content

Support Center